Bioneer



View all Products

AccuPrep® Nano-Plus Plasmid Mini Ex...
Bioneer introduces AccuPrep® Nano-Plus Plasmid DNA Extraction Kits - the first in a series of unique and revolutionary nucleic acid purif...

View Product

AccuPower® PCR PreMix
Bioneer’s AccuPower® PCR PreMix is a convenient lyophilized PCR master mix containing Top DNA Polymerase, dNTPs, reaction buffer, tracking ...

View Product

ExiSpin™ Combination Vortexer/Centr...
ExiSpin™ has the functions of a vortexer as well as a microcentrifuge and will significantly save you time in the lab. ExiSpin comes comp...

View Product

ExiProgen™ Automated Protein Synthe...
ExiProgen™ system is a breakthrough in synthetic biology that allows for rapid, small-scale in vitro synthesis and purification of up to ...

View Product

ExiPrep™ 16 Plus Automated Sample P...
ExiPrep™ 16 Plus is a laboratory automation system able to extract DNA or RNA from various biological samples including tissue, cell cult...

View Product

Browse All Bioneer Products (see all)

Browse Products by Field

Basic Research (85)

Environmental (8)

Food and Beverage (18)

Forensics (57)

General Lab (1)

Life Sciences (85)

PCR Special Feature (10)

Target Discovery (62)




Company Profile


Bioneer Corporation is the first Korean biotechnology company established in 1992. The company has developed state of art molecular biology products and technologies including oligonucleotides, thermostable polymerases, and instruments of gene manipulation (automatic nucleic acid extractor, thermal cycler, real-time QPCR instruments and DNA sequencer). From its inception, Bioneer has invested in the integration of recombinant DNA technology, fermentation, biochemistry and nucleic acid chemistry in addition to mechanics, photonics and electronics. The company is positioned to fully-integrate its capability to develop next generation technologies in the post-genome era through the invention of new biochemistry and instruments. Bioneer now runs two production and research facilities in Korea which are a total of 226,000 square feet. Equipped with proprietary 384 synthesizers, these facilities contain a full production line for oligonucleotide and siRNA synthesis. In addition to DNA manufacturing, Bioneer processes recombinant proteins which are fermented and purified on proprietary purification systems.

After a successful Initial Public Offering in December 2005, Bioneer Corp. launched Bioneer Inc., the wholly owned subsidiary. The American subsidiary is located in a 22,000 square foot production and distribution facility in Alameda, CA, the heart of the San Francisco Bay Area. The company is dedicated to providing state of art solutions to the global community of life science researchers in academia, biotech and pharmaceutical companies.

Mission

Bioneer’s mission is to become a solution provider in next-generation healthcare technologies in the fields of molecular diagnostics and therapeutics.

The company is to provide the best affordable products for the global healthcare market by application of its state-of-art technologies in molecular biology, DNA/RNA synthesis, nano-biotechnology, bio-automation and instrumentation.










Advertisement